Tyrosine kinase inhibitors in cancer therapy

被引:0
|
作者
Eckhardt, S. [1 ]
机构
[1] Natl Inst Oncol, H-1122 Budapest, Hungary
关键词
D O I
10.2174/187152008784533053
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:461 / 461
页数:1
相关论文
共 50 条
  • [1] Tyrosine kinase inhibitors in cancer therapy
    Madhusudan, S
    Ganesan, TS
    [J]. CLINICAL BIOCHEMISTRY, 2004, 37 (07) : 618 - 635
  • [2] Tyrosine kinase inhibitors as cancer therapy
    Nichols, GL
    [J]. CANCER INVESTIGATION, 2003, 21 (05) : 758 - 771
  • [3] Role of tyrosine kinase inhibitors in cancer therapy
    Arora, A
    Scholar, EM
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2005, 315 (03): : 971 - 979
  • [4] Protein tyrosine kinase inhibitors in cancer therapy
    Boutayeb, S.
    Zakkouri, F. Z.
    Aitelhaj, M.
    Mesmoudi, M.
    Boutayeb, A.
    Boutayeb, W.
    Mrabti, H.
    Errihani, H.
    [J]. PATHOLOGIE BIOLOGIE, 2012, 60 (04): : 229 - 233
  • [5] New tyrosine kinase and EGFR inhibitors in cancer therapy
    Rottlaender, D.
    Reda, S.
    Motloch, L. J.
    Hoppe, U. C.
    [J]. INTERNIST, 2011, 52 (10): : 1245 - +
  • [6] Smart drugs: Tyrosine kinase inhibitors in cancer therapy
    Shawver, LK
    Slamon, D
    Ullrich, A
    [J]. CANCER CELL, 2002, 1 (02) : 117 - 123
  • [7] Antiangiogenic therapy of cancer by multitargeted tyrosine kinase inhibitors
    Agata, Naoki
    [J]. JOURNAL OF PHARMACOLOGICAL SCIENCES, 2008, 106 : 40P - 40P
  • [8] Tyrosine kinase inhibitors for the therapy of anaplastic thyroid cancer
    Antonelli, Alessandro
    Fallahi, Poupak
    Ulisse, Salvatore
    Ferrari, Silvia Martina
    Mazzi, Valeria
    Di Domenicantonio, Andrea
    Miccoli, Paolo
    [J]. INTERNATIONAL JOURNAL OF ENDOCRINE ONCOLOGY, 2015, 2 (02) : 135 - 142
  • [9] Nanotechnology of Tyrosine Kinase Inhibitors in Cancer Therapy: A Perspective
    Russo, Eleonora
    Spallarossa, Andrea
    Tasso, Bruno
    Villa, Carla
    Brullo, Chiara
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (12)
  • [10] Acquired resistance to tyrosine kinase inhibitors during cancer therapy
    Engelman, Jeffrey A.
    Settleman, Jeffrey
    [J]. CURRENT OPINION IN GENETICS & DEVELOPMENT, 2008, 18 (01) : 73 - 79